ClinicalTrials HQ

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Active, not recruiting · NCT04858776 · Registry updated 2026-06-25
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVTEmbolism and Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorderActive, not recruitingPhase 22026-06-25NCT04858776

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Mercator MedSystems, Inc.3

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CardioVoyageDenisonUnited States1
CIS Clinical ResearchHoumaUnited States2
Galway University HospitalGalwayIreland12
Guy's and St. Thomas HospitalLondonUnited Kingdom2
Lake Washington VascularBellevueUnited States2
MedStar Health Research InstituteHyattsvilleUnited States11
NC Heart and Vascular ResearchRaleighUnited States12
Northwestern University HospitalChicagoUnited States3
OhioHealth Research InstituteColumbusUnited States18
Sentara Norfolk General HospitalNorfolkUnited States2
St John Health SystemBartlesvilleUnited States1
Stony Brook University HospitalStony BrookUnited States52
University of South FloridaTampaUnited States2
University of Texas, HoustonHoustonUnited States1
Vascular Care ConnecticutDarienUnited States4